Thyroid cancer imaging in vivo by targeting the anti-apoptotic molecule galectin-3.
<h4>Background</h4>The prevalence of thyroid nodules increases with age, average 4-7% for the U.S.A. adult population, but it is much higher (19-67%) when sub-clinical nodules are considered. About 90% of these lesions are benign and a reliable approach to their preoperative characteriza...
Guardado en:
Autores principales: | Armando Bartolazzi, Calogero D'Alessandria, Maria Gemma Parisella, Alberto Signore, Fabrizio Del Prete, Luca Lavra, Sten Braesch-Andersen, Roberto Massari, Carlo Trotta, Alessandro Soluri, Salvatore Sciacchitano, Francesco Scopinaro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4829821531024d6984357829312b9852 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effective rational humanization of a PASylated anti-galectin-3 Fab for the sensitive PET imaging of thyroid cancer in vivo
por: Emanuel Peplau, et al.
Publicado: (2021) -
ApoE production in human monocytes and its regulation by inflammatory cytokines.
por: Sten Braesch-Andersen, et al.
Publicado: (2013) -
Does Diabetes Alter Immunolocalization of Galectin-1 and Galectin-3 in the Rat Ovary?
por: Özdenoglu,Berna, et al.
Publicado: (2016) -
Galectin-3 Inhibits Galectin-8/Parkin-Mediated Ubiquitination of Group A Streptococcus
por: Yi-Lin Cheng, et al.
Publicado: (2017) -
The role of Galectin-1 and Galectin-3 in the mucosal immune response to Citrobacter rodentium infection.
por: Renata Curciarello, et al.
Publicado: (2014)